| Financial Year |
March 31 2023 |
| Monetary Funds |
661,450,825.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
351,010,261.70 |
| Advances to Suppliers |
72,420,756.56 |
| Other Receivables |
61,558,170.70 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
985,031,579.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
22,870,744.34 |
| Total Current Assets |
2,154,342,338.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
81,291,693.55 |
| Under-construction Projects |
3,132,205.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,282,723,744.46 |
| R&D expenses |
-- |
| Goodwill |
1,825,130,713.14 |
| Long-Term Deferred and Prepaid Expenses |
119,360,723.07 |
| Deferred Income Tax Assets |
295,759,721.00 |
| Other Non-Current Assets |
2,330,764.80 |
| Sub-Total of Non-Current Assets |
3,822,825,104.20 |
| Total Assets |
5,977,167,442.56 |
| Short-Term Loans |
438,173,715.60 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
419,554,425.80 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
66,915,844.28 |
| Taxes Payable |
40,946,650.40 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
148,179,845.46 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
413,499,962.76 |
| Other Current Liabilities |
44,532,418.94 |
| Sub-Total of Current Liabilities |
1,639,713,559.95 |
| Long-term Loans |
740,982,914.35 |
| Bonds Payable |
271,136,489.41 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,074,967.57 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,134,734,316.67 |
| Total Liabilities |
2,774,447,876.62 |
| Paid-In Capital(Or Share Stock) |
347,206,650.00 |
| Capital Surplus |
2,021,360,261.25 |
| Surplus Reserve |
107,946,853.36 |
| LESS:Treasury Stock |
39,113,610.12 |
| Undistributed Profits |
724,766,753.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,202,719,565.94 |
| Owner's Equity（Stockholder's Equity） |
3,202,719,565.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,977,167,442.56 |
